Learn more

NOVO NORDISK HEALTHCARE AG

Overview
  • Total Patents
    851
  • GoodIP Patent Rank
    15,356
  • Filing trend
    ⇩ 22.0%
About

NOVO NORDISK HEALTHCARE AG has a total of 851 patent applications. It decreased the IP activity by 22.0%. Its first patent ever was published in 1986. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are TIANSHILI PHARM CO LTD, HALOZYME INC and BIOAXONE BIOSCIENCES INC.

Patent filings per year

Chart showing NOVO NORDISK HEALTHCARE AGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Olsen Ole Hvilsted 89
#2 Persson Egon 74
#3 Jensen Michael Bech 70
#4 Behrens Carsten 65
#5 Rojkjaer Rasmus 60
#6 Kornfelt Troels 56
#7 Johansen Nils Langeland 51
#8 Hansen Birthe Lykkegaard 50
#9 Krarup Janus 49
#10 Andersen Henrik Sune 34

Latest patents

Publication Filing date Title
WO2017009136A1 Factor xiii for the treatment of interstitial cystitis
WO2016034534A1 Lysine rich basic pre-sequences
EP3104892A1 Coagulation factor ix conjugates
US2016303248A1 Method for Thioether Conjugation of Proteins
TW201533058A Coagulation factor VII polypeptides
KR20160065925A Coagulation factor vii polypeptides
WO2015036553A1 Thiol functionalized polymers
WO2014166836A1 Growth hormone compound formulation
CN105229035A Growth hormone compound
WO2014060512A1 Fatty acid acylated amino acids for growth hormone delivery
WO2014060397A1 Factor vii conjugates
EP2906693A1 Coagulation factor vii polypeptides
EP2906236A1 Liquid pharmaceutical composition of factor vii polypeptide
CN104394906A Method of manufacturing a medical device
AU2013204527A1 Growth hormones with prolonged in-vivo efficacy
BR112014013551A2 medical device that has integrated sequence control
WO2013076129A1 Barrier element removal
WO2013053949A1 Pre-assembled fluid transfer arrangement
WO2013053935A1 Sterile spike compartment
AU2012213951A1 A closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit